Rallybio Corporation
RLYB
$0.67
$0.023.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.17M | -41.65M | -48.19M | -57.78M | -66.97M |
| Total Depreciation and Amortization | 119.00K | 116.00K | 124.00K | 131.00K | 137.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -15.34M | 8.40M | 8.64M | 8.62M | 9.05M |
| Change in Net Operating Assets | -5.61M | -8.86M | -4.61M | -258.00K | 6.72M |
| Cash from Operations | -35.00M | -41.99M | -44.03M | -49.28M | -51.07M |
| Capital Expenditure | -- | -- | -- | -- | -12.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 41.77M | 34.75M | 34.31M | 33.49M | 51.99M |
| Cash from Investing | 41.77M | 34.75M | 34.31M | 33.49M | 51.97M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 28.00K | 28.00K | 5.47M | 5.47M | 5.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -11.00K | -268.00K | -268.00K | -269.00K |
| Cash from Financing | 28.00K | 17.00K | 5.20M | 5.20M | 5.25M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.80M | -7.23M | -4.52M | -10.59M | 6.16M |